Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials

OBJECTIVE: Clinical trials are increasingly globalized, and adverse event (AE) rates and treatment responses may differ by geographical region. This study assessed regional differences in AE reporting rates and ACR response rates (ACR20/50) in patients with RA who received placebo/standard-of-care t...

Descripción completa

Detalles Bibliográficos
Autores principales: Keebler, Daniel, Teng, Edmond, Chia, Jenny, Galanter, Joshua, Peake, Jodie, Tuckwell, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516100/
https://www.ncbi.nlm.nih.gov/pubmed/32182362
http://dx.doi.org/10.1093/rheumatology/keaa043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516100/
https://www.ncbi.nlm.nih.gov/pubmed/32182362
http://dx.doi.org/10.1093/rheumatology/keaa043

Ejemplares similares